Last reviewed · How we verify
Ethinyl estradiol and norgestimate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ethinyl estradiol and norgestimate (Ethinyl estradiol and norgestimate) — University of Vermont.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ethinyl estradiol and norgestimate TARGET | Ethinyl estradiol and norgestimate | University of Vermont | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ethinyl estradiol and norgestimate CI watch — RSS
- Ethinyl estradiol and norgestimate CI watch — Atom
- Ethinyl estradiol and norgestimate CI watch — JSON
- Ethinyl estradiol and norgestimate alone — RSS
Cite this brief
Drug Landscape (2026). Ethinyl estradiol and norgestimate — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-and-norgestimate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab